Mirum Pharmaceuticals, Inc. (MIRM)
96.39
-5.11
(-5.03%)
USD |
NASDAQ |
Jun 01, 16:00
96.39
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals EPS Diluted (Quarterly) : -13.43 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| Travere Therapeutics, Inc. | -0.3984 |
| Incyte Corp. | 1.467 |
| Vertex Pharmaceuticals, Inc. | 4.024 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -790.16M |
| Revenue (Quarterly) | 159.88M |
| Total Expenses (Quarterly) | 950.04M |
| Enterprise Value | 6.127B |
| Gross Profit Margin (Quarterly) | 81.94% |
| Profit Margin (Quarterly) | -494.2% |
| Earnings Yield | -14.11% |
| Normalized Earnings Yield | -5.164 |